tyrphostin ag957 has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biden, TJ; Carpenter, L; Fields, AP; Jamieson, L | 1 |
| Bozzi, A; Brisdelli, F; Ferretti, A; Iorio, E; Knijn, A; Marcheggiani, D | 1 |
2 other study(ies) available for tyrphostin ag957 and paclitaxel
| Article | Year |
|---|---|
Protein kinase Ciota activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis.
Topics: 3T3 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Enzyme Activation; Enzyme Inhibitors; Fusion Proteins, bcr-abl; HL-60 Cells; Humans; Isoenzymes; Mice; Paclitaxel; Protein Kinase C; Protein-Tyrosine Kinases; Tumor Cells, Cultured; Tyrphostins | 1999 |
Metabolic alterations in K562 cells exposed to taxol and tyrphostin AG957: 1H NMR and biochemical studies.
Topics: Antineoplastic Agents, Phytogenic; Buthionine Sulfoximine; Glutathione; Humans; Inositol; K562 Cells; Lipid Metabolism; Magnetic Resonance Spectroscopy; Models, Statistical; Paclitaxel; Phospholipids; Phosphorylcholine; Time Factors; Tyrphostins | 2005 |